(Press-News.org) Women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD) have a higher risk of perinatal depression. Conversely, women with perinatal depression have a higher risk of developing premenstrual disorders. This is shown in a study from Karolinska Institutet published in the journal PLOS Medicine.
Premenstrual disorders like PMS or PMDD and perinatal depression are similar in the way that symptoms appear in connection with hormonal changes. This fact has given rise to the hypothesis that the disorders share both causes and risk factors. Now a study by researchers at Karolinska Institutet shows a bidirectional association between premenstrual disorders and perinatal depression.
“We can show that women with PMS or PMDD have a higher risk of developing perinatal depression and vice versa,” says Qian Yang, affiliated researcher at the Institute of Environmental Medicine, Karolinska Institutet and one of the main authors of the paper. “The results support the hypothesis that the diseases might have common causes.”
Between 2001 and 2018, approximately 1,800,000 pregnancies were registered in the Swedish Medical Birth Register. Among these, the researchers were able to identify nearly 85,000 women who suffered from perinatal depression. Additional national registers, such as the patient register and the drug register, were also used to identify women diagnosed with PMS or PMDD. These were then compared to a control group of nearly 850,000 birthing women who did not develop perinatal depression during the same period.
The results showed that women with premenstrual disorders were five times more likely to experience perinatal depression. Conversely, women who experienced perinatal depression were twice as likely to develop premenstrual disorders.
The bidirectional association was noted for both prenatal and postnatal depression, regardless of history of psychiatric disorders.
“It is important that healthcare professionals who meet with women during pregnancy are aware of the link between premenstrual disorders and perinatal depression in order to provide well-informed advice,” says Donghao Lu, Associate Professor at the Institute of Environmental Medicine, Karolinska Institutet and last author of the paper.
The authors emphasize that more research is needed to understand the biological link between premenstrual disorders and perinatal depression. In addition, more information is needed to clarify whether the association also applies to women with mild PMS or perinatal depression.
The study was financed by Karolinska Institutet, Forte, the Swedish Research Council and the Icelandic Research Fund, among others. The researchers declare that there are no conflicts of interest.
Publication: "The bidirectional association between premenstrual disorders and perinatal depression: a nationwide register-based study from Sweden". Qian Yang, Emma Bränn, Elizabeth R. Bertone-Johnson, Arvid Sjölander, Fang Fang, Anna Sara Oberg, Unnur A. Valdimarsdóttir and Donghao Lu. PLOS Medicine, online 28 March 2024, doi: 10.1371/journal.pmed.1004363.
END
Bidirectional link between premenstrual disorders and perinatal depression
2024-03-28
ELSE PRESS RELEASES FROM THIS DATE:
Cell division quality control ‘stopwatch’ uncovered
2024-03-28
Each day, hundreds of billions of cells in our body cycle through a period of growth and division. Yet in that time, only about 30 minutes is spent on the critical orchestration of mitosis, when chromosomes are carefully segregated from one parent cell to the next generation of two daughter cells.
It’s during this crucial period of cell division that things can go haywire. Chromosomes can be misdirected, leading to damaged and diseased cells that progress to different types of cancer. University of California San Diego scientists reporting in the journal Science have found a key mechanism that keeps track of mitosis timing and ...
Vaccine protects cattle from bovine tuberculosis, may eliminate disease
2024-03-28
UNIVERSITY PARK, Pa. — Bovine tuberculosis (TB) is a livestock disease that results in large economic losses to animal agriculture worldwide. The disease can also transmit to humans and cause severe illness and death. Researchers from Penn State, Addis Ababa University and the University of Cambridge have now demonstrated that a vaccine for TB currently used in humans significantly reduces infectiousness of vaccinated livestock, improving prospects for elimination and control. The study published today (March 28) in the journal Science.
The spillover ...
Andrew Siemion to receive the SETI Institute’s 2024 Drake Award
2024-03-28
March 28, 2024, Mountain View, CA -- The SETI Institute is pleased to announce that Dr. Andrew Siemion will be honored with the prestigious 2024 Drake Award for his exceptional and pioneering contributions to SETI and radio astronomy and his leadership in the field. Siemion's distinguished career includes his role as the Bernard M. Oliver Chair for SETI at the SETI Institute, Principal Investigator for the Breakthrough Listen Initiative at the University of Oxford, along with holding an Honorary Professorship ...
New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells
2024-03-28
Researchers at Karolinska Institutet, in collaboration with JLP Health and others, have identified how the tick-borne Crimean-Congo haemorrhagic fever virus enters our cells. The results are published in Nature Microbiology and are an important step in the development of drugs against the deadly disease.
Crimean-Congo haemorrhagic fever virus (CCHF virus) is spread through tick bites and can cause haemorrhagic fever. The disease is serious and has a mortality rate of up to 40 per cent depending on the health status of the person infected. Common symptoms ...
Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma
2024-03-28
In a recent multi-center study published in the Journal of the National Cancer Institute, researchers examined the effects of neoadjuvant chemotherapy (NAC) on patients suffering from locally advanced penile squamous cell carcinoma (PSCC). Dr. Kyle Rose, urologic oncologist at Ochsner MD Anderson Cancer Center, was the lead author for the publication.
The research included a cohort of 209 patients undergoing NAC, targeting locally advanced and clinically node positive PSCC. The patient group showed a diverse range of disease severity, with a distribution including 7% with stage II, 48% with stage III, and 45% with stage IV PSCC, ...
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
2024-03-28
(MEMPHIS, Tenn. – March 28, 2024) Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children’s Research Hospital scientists demonstrated that in bilateral Wilms tumor (cancer in both kidneys) chemotherapy resistance can point toward a more favorable histology and an ultimatelygood outcome. The study revealed that tumors that do not respond to neoadjuvant, or tumor-shrinking, chemotherapy are predominantly ...
Doctors received approximately $12.1 billion from drug and device makers between 2013-2022
2024-03-28
HERSHEY, Pa. — Despite evidence that financial conflicts of interest may influence medical practice and research and may erode patient trust in medical professionals, these relationships remain pervasive. According to a new analysis of the Open Payments platform, a database that tracks payments between physicians and industry, a team led by a Penn State researcher found that doctors received approximately $12.1 billion from drug and device makers between 2013 and 2022.
Their findings published today (March 28) in JAMA. It’s one of the first studies to look at industry payments longitudinally and by specialty.
“Overall, ...
Discovery suggests new strategy against follicular lymphoma
2024-03-28
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.
The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs.
“These encouraging findings could address critical and urgent challenges with this disease and have prompted us to begin planning clinical trials ...
Making the future too bright: how wishful thinking can point us in the wrong direction
2024-03-28
Everyone indulges in wishful thinking now and again. But when is that most likely to happen and when could it actually be harmful? A new study, led by the University of Amsterdam (UvA), demonstrates unequivocally that the greater the insecurity and anxiety of a situation, the more likely people are to become overly optimistic – even to the point where it can prevent us from taking essential action. The study's results have now been published in the journal American Economic Review.
‘People aren't purely truth-seekers - many beliefs are influenced by ...
Ochsner Health named to Newsweek’s America’s Greatest Workplaces 2024 for Job Starters
2024-03-28
NEW ORLEANS, La – Newsweek and Plant-A Insights Group have named Ochsner Health one of America's Greatest Workplaces for Job Starters in 2024. In a survey that included more than 75,000 young professionals and more than 540,000 company reviews, Ochsner earned 5 out of 5 stars. As the leading not-for-profit healthcare provider in the Gulf South, Ochsner is committed to championing career development among new professionals.
"We at Ochsner are honored to receive recognition as a place of employment that offers ...